Katarina Nägga - Concepedia

Author

Katarina Nägga

Also Known As

Elin Byman, K Nagga, K Nägga, K. Nagga, K. Nägga, Katarina Nagga, Katarina Nägga, Katarina Nägga, Lennart Minthon, Maria Nilsson

135

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Lund University Skåne University Hospital Linköping University Karolinska University Hospital University of Gothenburg

About

Katarina Nägga is an author at Lund University specializing in medicine, neurology, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.2K
2	Health Sciences	8	8	609
3	Social Sciences	4	4	112
4	Public Health	3	3	226
5	Nursing	2	2	102

Katarina Nägga

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders Sara Hall, Annika Öhrfelt, Radu Constantinescu, Archives of Neurology	2012	470
Tau and Aβ42 in Cerebrospinal Fluid from Healthy Adults 21–93 Years of Age: Establishment of Reference Values Magnus Sjögren, Hugo Vanderstichele, Hans Ågren, Clinical Chemistry	2001	436
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival Tobias Skillbäck, Bahman Farahmand, Jonathan W. Bartlett, Neurology	2014	265
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype Shorena Janelidze, Joakim Hertze, Katarina Nägga, Neurobiology of Aging Bbb PermeabilityApoe GenotypeBlood-brain Barrier PermeabilityNeurochemical BiomarkersCerebral Vascular Regulation	2016	220
Cerebrospinal fluid tau and amyloid-β<sub>1-42</sub>in patients with dementia Tobias Skillbäck, Bahman Farahmand, Christoffer Rosén, Brain	2015	215
The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort Emma Borland, Katarina Nägga, Peter M. Nilsson, Journal of Alzheimer s Disease	2017	207
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease Oskar Hansson, Sara Hall, Annika Öhrfelt, Alzheimer s Research & Therapy	2014	200
SveDem, the Swedish Dementia Registry – A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice Dorota Religa, Seyed‐Mohammad Fereshtehnejad, Pavla Čermáková, PLoS ONE	2015	173
Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease Jonathan A. Prince, Lars Feuk, Sarah L. Sawyer, European Journal of Human Genetics Genome-wide Association StudyDisease HeterogeneityAlzheimer's DiseaseSporadic AlzheimerGenetics	2001	142
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease Mikko Hölttä, Oskar Hansson, Ulf Andréasson, PLoS ONE Neurochemical BiomarkersAlzheimer ’Alzheimer's DiseaseCerebrospinal FluidProtein Misfolding	2013	134

Page 1